Carcinoma of the Pancreas

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Pancreas adenocarcinoma is now the 10th-leading cause of cancer in the United States but the fourth leading cause of cancer-related death. By 2030, it is expected to be the second-leading cause of cancer-related death in the United States after lung cancer. Understanding the genetics, molecular biology, and immunology of pancreas cancer has been key to making inroads in developing new therapies. This chapter highlights recent progress.

Original languageEnglish (US)
Title of host publicationAbeloff’s Clinical Oncology
PublisherElsevier
Pages1342-1360.e7
ISBN (Electronic)9780323476744
DOIs
StatePublished - Jan 1 2019

Keywords

  • FOLFIRINOX
  • Gemcitabine and abraxane
  • Mismatch repair deficiency
  • Progression model
  • Tumor micro environment

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Carcinoma of the Pancreas'. Together they form a unique fingerprint.

Cite this